Skip to main content Back to Top


Hydroxocobalamin Solution for Intramuscular Injection

Products Affected - Description

    • Hydroxocobalamin intramuscular solution for injection, Teva, 1,000 mcg/mL, 30 mL multiple dose vial, NDC 00591-2888-30

Reason for the Shortage

    • Teva did not provide a reason for the shortage.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Teva has hydroxocobalamin 1,000 mcg/mL solution for intramuscular injection in 30 mL vials on intermittent back order and the company is releasing supplies as they become available.


Updated June 23, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created September 8, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.


Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.